Cough, Cold and Allergy (Hay Fever) Remedies in Israel

PROSPECTS

Growth slows due to shorter, warmer winters

Cough, cold and allergy remedies are very seasonal products and are therefore much affected by the changes in weather and climate. Therefore, as winters have been getting shorter and warmer, volume growth has slowed down significantly and is set to continue decreasing over the forecast period.

Paediatric cough/cold remedies dominated by nasal sprays

Several paediatric cough/cold remedies were taken off the shelves two years ago after the Ministry of Health banned the use of pseudoephedrine in combination with other components in paediatric remedies. These include products such as Acamoli Cold and Sinufed Kid, which have not been replaced by other, pseudoephedrine-free versions, but instead simply disappeared from the market.

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries reclaims leading OTC portfolio

Teva Pharmaceutical Industries Ltd leads the category thanks to its brands Acamol and Coldex, which are dominant in combination products, and Alrin, which is dominant in nasal sprays. These brands are widely recognised, and often consumers' go-to products for congestion and colds.

Dexcel Pharma and GSK support strong brands

Dexcel Pharma Ltd and GSK Consumer Healthcare both gained share during the past two years, thanks to their dominance in large or growing subcategories such as combination products, with Dexcel's Dexamol Cold, and GSK's Otrivin. With these strong brands, which are both supported by seasonal advertising campaigns, they are expected to continue gaining share over the forecast period too, although actual sales may decrease due to the general slowdown in the category.

Files are delivered directly into your account within a few minutes of purchase.